Clinical Guides
Hypopituitarism
A clinically focused guide to recognising and managing adult hypopituitarism in India, with explicit safeguards for adrenal insufficiency, dynamic testing, pregnancy, tumour surveillance and individualized hormone replacement.
MedNext Academy | 12 min read
Hypopituitarism
A clinically focused guide to recognising and managing adult hypopituitarism in India, with explicit safeguards for adrenal insufficiency, dynamic testing, pregnancy, tumour surveillance and individualized hormone replacement.
Summary
Hypopituitarism is partial or complete deficiency of one or more anterior or posterior pituitary hormones caused by disease of the hypothalamic-pituitary region or its treatment. Presentation may be abrupt, as after pituitary apoplexy, or insidious with fatigue, menstrual disturbance, sexual dysfunction, infertility, loss of body hair, hyponatraemia, reduced muscle mass, growth failure or impaired stress tolerance. Symptoms are nonspecific, so diagnosis requires biochemical evidence interpreted alongside illness, medicines, menstrual or pregnancy status, and structural imaging. A vital sequencing rule is to evaluate and protect the cortisol axis before starting levothyroxine: thyroid hormone can increase cortisol clearance and precipitate adrenal crisis in an unrecognized corticotropin deficiency. Morning cortisol and free thyroxine are anchor tests, but equivocal adrenal or growth-hormone results may require validated dynamic testing in an experienced unit. Replacement aims to reproduce physiology without causing overtreatment; glucocorticoid education and emergency planning are as important as the prescription. Sex-steroid, growth-hormone and desmopressin decisions are individualized, including fertility goals, pregnancy, comorbidity and affordability. The underlying lesion still needs attention through pituitary MRI, visual assessment, neurosurgical review or oncological treatment where indicated. In India, assay availability, dynamic-test supervision, pituitary MRI and specialist surgery vary greatly, making clear referral, written sick-day instructions and continuity between local clinicians and tertiary endocrinology central to safe care. This draft is educational, not a patient-specific protocol, and requires organizational clinical review before publication.
How Common Is It?
Population estimates are imprecise because hypopituitarism is a syndrome with many causes, mild deficiencies are easily missed, and registries preferentially capture patients attending specialist centres. Prevalence rises among survivors of pituitary tumours, cranial irradiation, traumatic brain injury, subarachnoid haemorrhage, infiltrative disease and postpartum pituitary injury. The number of affected people is therefore determined not only by spontaneous pituitary disease but also by improved survival after neurosurgery, radiotherapy and childhood cancer treatment. Published estimates from referral cohorts should not be presented as an Indian national rate: India lacks a comprehensive population registry and access to endocrine testing is uneven. Sheehan syndrome remains clinically important where severe obstetric haemorrhage and delayed recognition occur, while nonfunctioning adenomas and treatment-related deficiencies dominate many tertiary clinics. Selective hormone loss is more common than complete panhypopituitarism, and deficiencies can emerge years after irradiation. Clinical vigilance should be risk-based rather than prevalence-based: a compatible history plus unexplained endocrine features justifies directed testing even when a patient does not resemble a classic textbook case.
Risk Factors
The strongest risk factors are lesions or interventions that damage the hypothalamus, pituitary gland or stalk. They include pituitary macroadenoma, craniopharyngioma, Rathke cleft cyst, germinoma, metastasis, neurosurgery and radiotherapy involving the sellar region. Postpartum haemorrhage with hypotension raises concern for Sheehan syndrome; severe headache or acute visual symptoms may indicate apoplexy. Traumatic brain injury, subarachnoid haemorrhage, lymphocytic hypophysitis, sarcoidosis, tuberculosis, haemochromatosis and other infiltrative or inflammatory disorders broaden the differential. Immune-checkpoint inhibitors can cause hypophysitis, while long-term exogenous glucocorticoids suppress the hypothalamic-pituitary-adrenal axis without necessarily producing structural pituitary disease. Childhood cranial irradiation can lead to delayed, sequential hormone loss, so normal early testing does not eliminate future risk. Pregnancy can enlarge a pre-existing pituitary lesion or reveal lymphocytic hypophysitis, although most pregnancies in stable, appropriately managed disease are successful. Genetic transcription-factor defects and developmental abnormalities matter particularly in childhood or familial presentations. Risk assessment must also identify medicines that distort measurements, including glucocorticoids, opioids, antipsychotics, oestrogens and thyroid preparations. No single risk factor proves deficiency; it establishes the pre-test probability that determines which basal tests, dynamic tests, imaging and specialist follow-up are justified.
Diagnosis
History
Ask about pituitary tumours, cranial surgery or irradiation, head injury, postpartum haemorrhage, severe headache, visual change, polyuria, polydipsia and relevant medicines. Elicit fatigue, weight change, postural symptoms, nausea, hypoglycaemia, cold intolerance, constipation, menstrual pattern, libido, erectile function, fertility, shaving frequency and loss of axillary or pubic hair. Document pregnancy intentions and prior adrenal crises. Acute headache, vomiting, ophthalmoplegia, altered consciousness or visual loss requires emergency assessment for apoplexy rather than routine outpatient testing.
Examination
Record lying and standing blood pressure, pulse, weight, hydration, pigmentation pattern, body hair, testicular volume where appropriate, galactorrhoea, thyroid features and Cushingoid evidence of exogenous steroids. Assess visual acuity, fields and ocular movements when a mass is possible. Look for features of the causal disorder, including cranial neuropathy, systemic inflammation or iron overload. Examination can support but cannot exclude pituitary deficiency.
Investigations
Obtain paired 08:00-09:00 serum cortisol when central adrenal insufficiency is suspected, accounting for recent glucocorticoid exposure and altered binding proteins. Very low results strongly support deficiency; intermediate results require an appropriate stimulation test, whereas local assay-specific interpretation is essential. Measure free T4 with TSH: a low free T4 with low, normal or mildly raised TSH in pituitary disease supports central hypothyroidism, and TSH alone is unsafe for screening or dose titration. Assess prolactin, sodium, osmolality, gonadotropins with sex steroids, and IGF-1 according to presentation. Adult growth-hormone deficiency usually needs validated stimulation testing unless there is a compelling structural and multi-axis context. Pituitary MRI with contrast defines anatomy; formal visual fields are indicated when the lesion approaches the optic apparatus. Dynamic testing belongs in a supervised unit with contraindications, sampling times and assay method documented.
Differential Diagnosis
Common symptoms overlap with anaemia, chronic infection, malignancy, renal or hepatic disease, heart failure, depression, sleep disorders, malnutrition and medication adverse effects. Primary endocrine disease must be separated from central deficiency: primary hypothyroidism usually produces a clearly raised TSH, while primary adrenal failure more often causes hyperkalaemia and ACTH-driven pigmentation; neither distinction is absolute during acute illness or treatment. Functional hypothalamic amenorrhoea, menopause, hyperprolactinaemia, polycystic ovary syndrome and primary gonadal failure can mimic gonadotropin deficiency. Exogenous glucocorticoids, opioids and anabolic steroids suppress axes and may be the actual cause. Critical illness produces adaptive changes in thyroid, cortisol and gonadal measurements that should not be overlabelled as chronic hypopituitarism. Diabetes insipidus suggests stalk, hypothalamic or infiltrative disease and is uncommon in a simple pituitary adenoma; primary polydipsia and osmotic diuresis are alternatives. Low IGF-1 is not specific for growth-hormone deficiency because malnutrition, liver disease and poorly controlled diabetes reduce it. Conversely, a normal IGF-1 does not always exclude adult deficiency. The differential must address both the hormonal pattern and the cause of any sellar lesion, including nonfunctioning adenoma, hypophysitis, infection, metastasis and vascular injury.
Management
Immediate priorities are adrenal safety and treatment of any compressive or acute pituitary lesion. If adrenal crisis or apoplexy with haemodynamic compromise is suspected, take blood for cortisol if this causes no delay, give parenteral hydrocortisone and isotonic fluid, correct hypoglycaemia and involve endocrinology, neurosurgery and ophthalmology urgently. In stable disease, replace proven deficiencies in a deliberate order. Establish glucocorticoid cover before levothyroxine; then titrate levothyroxine to clinical status and free T4 rather than TSH. Replace gonadal steroids when appropriate after discussing contraindications, bone health, fertility and patient preference. Fertility usually requires specialist gonadotropin or pulsatile GnRH treatment rather than ordinary sex-steroid replacement. Consider growth hormone only after other axes are optimized and confirmed deficiency, contraindications, expected benefit, monitoring burden and cost have been reviewed. Desmopressin for central diabetes insipidus requires careful fluid advice and sodium monitoring; excessive dosing can cause dangerous hyponatraemia. Treat the cause with observation, transsphenoidal surgery, radiotherapy or disease-specific therapy according to lesion behaviour and multidisciplinary assessment. Build a written follow-up plan covering symptoms, free T4, electrolytes, sex-steroid endpoints, bone health, metabolic risk and periodic tumour imaging. Reassess axes after surgery, pregnancy, radiotherapy, major weight change or new symptoms. Evidence supports replacement principles more strongly than any single universal regimen, so individualization and specialist oversight are essential.
Prescribing Information
Hydrocortisone is commonly divided to approximate daytime cortisol exposure, using the lowest dose that prevents deficiency without chronic glucocorticoid excess. Exact dosing and alternatives depend on the endocrinologist, formulation availability, comorbidity and adherence. Every patient with central adrenal insufficiency needs written sick-day rules, a steroid emergency card or equivalent identification, access to injectable emergency hydrocortisone where feasible, and training for the patient and family. Fever, significant infection, trauma, surgery or inability to take tablets requires prompt dose escalation or parenteral treatment under a defined plan. Levothyroxine must not be commenced until cortisol sufficiency is established or glucocorticoid cover is provided. Central hypothyroidism is monitored with free T4 and symptoms because TSH can remain low or normal despite inadequate replacement. Oestrogen route changes thyroid-binding proteins and may alter levothyroxine requirements. Testosterone or oestrogen-progestogen therapy needs individual contraindication review, appropriate cancer and haematocrit surveillance, and attention to thrombotic risk. Growth hormone begins at a low individualized dose and is adjusted using clinical response, adverse effects and age-adjusted IGF-1; oedema, arthralgia, carpal-tunnel symptoms and glucose deterioration can occur. Desmopressin dosing should preserve some capacity for free-water excretion, with education about thirst, fluid intake and hyponatraemia. Never assume that replacing one axis corrects the others, and never stop chronic glucocorticoid replacement abruptly without specialist assessment.
When to Refer
Refer suspected hypopituitarism to endocrinology when basal results suggest central adrenal or thyroid deficiency, two or more axes are abnormal, dynamic testing is needed, or there is a sellar lesion, previous cranial irradiation, pregnancy, fertility need or persistent diagnostic uncertainty. Urgent same-day referral is warranted for suspected adrenal crisis, pituitary apoplexy, new visual-field loss, ophthalmoplegia, altered consciousness, severe hyponatraemia or rapidly progressive neurological symptoms. A lesion touching or compressing the optic chiasm needs formal visual assessment and pituitary multidisciplinary review; neurosurgery is involved when there is visual compromise, apoplexy, tumour growth or another operative indication. Refer women planning pregnancy before conception so hormone replacement, tumour size and surveillance can be reviewed. Children, adolescents and transition-age patients need paediatric or transition endocrinology because growth, puberty and dosing differ from adult care. Patients receiving radiotherapy need long-term endocrine surveillance even if early tests are normal. In resource-limited settings, referral should state the suspected deficient axes, emergency steroid status, relevant medicines, visual findings and available imaging so tertiary teams can prioritize safely. Local clinicians remain essential for repeat prescriptions, illness education and early crisis recognition after specialist decisions are made.
Red Flags
Hypotension, collapse, vomiting, abdominal pain, fever, hypoglycaemia, confusion or severe weakness in a person with known or possible ACTH deficiency may represent adrenal crisis and requires immediate treatment, not a delayed outpatient cortisol result. Sudden severe headache with visual loss, diplopia, ophthalmoplegia, meningism or reduced consciousness suggests pituitary apoplexy; urgent glucocorticoid cover, imaging and multidisciplinary evaluation are required. Severe hyponatraemia, seizure or deteriorating mental state may reflect cortisol deficiency, inappropriate water handling or desmopressin excess. New polyuria and polydipsia after pituitary surgery require prompt sodium and fluid assessment because diabetes insipidus can evolve or alternate with hyponatraemic phases. Progressive visual-field loss or cranial-nerve palsy indicates mass effect. During pregnancy, severe headache, visual symptoms, vomiting beyond the expected pattern or haemodynamic instability warrants urgent endocrine and obstetric assessment. Patients unable to retain oral glucocorticoids must use their emergency plan and seek care. A red flag can coexist with apparently modest biochemical abnormalities, especially after recent steroid exposure or in acute illness; management follows clinical risk while confirmatory testing proceeds.
Indian Clinical Context
India combines excellent pituitary centres with districts where endocrine assays, stimulation tests, pituitary MRI, neuro-ophthalmology and transsphenoidal surgery are difficult to access. A pragmatic pathway starts with careful history, examination, sodium, paired morning cortisol, free T4 with TSH, prolactin and targeted gonadal tests, followed by early specialist discussion rather than indiscriminate panels. Cortisol assay platforms and reference intervals differ, so imported numerical cut-offs must not be applied without the local laboratory method. Insulin tolerance testing needs trained staff, emergency equipment and contraindication screening; safer alternatives may be chosen by the specialist but are not interchangeable without validated protocols. MRI cost and travel can delay diagnosis, making documentation of visual symptoms and urgent referral thresholds particularly important. Hydrocortisone availability, emergency injection supply and medical identification vary; patients should receive simple written instructions in a language they understand and identify the nearest facility able to give parenteral steroids. Obstetric history must explicitly include postpartum haemorrhage, failure to lactate and amenorrhoea because delayed Sheehan syndrome remains relevant. Replacement choices may be constrained by cost, but affordability does not justify unsafe sequencing or monitoring. Teleconsultation can support continuity, while dynamic testing, complex pregnancy care, surgery and radiotherapy planning should remain anchored to experienced tertiary teams.
NMC Competency Mapping
This guide supports competency-based learning in the endocrine presentation of fatigue, hypotension, amenorrhoea, sexual dysfunction, hyponatraemia and sellar mass effects. The learner should be able to construct a problem representation, identify which hypothalamic-pituitary axes may be affected, select and interpret paired hormone measurements, explain why a trophic hormone can be inappropriately normal, and distinguish basal from dynamic testing. Demonstrable safety competencies include recognizing adrenal crisis and pituitary apoplexy, giving initial emergency care, and stating that cortisol evaluation or cover precedes levothyroxine. Prescribing learning includes glucocorticoid sick-day education, free-T4-guided central hypothyroidism treatment, and the limitations of sex-steroid, desmopressin and growth-hormone replacement. Communication competencies include counselling about medical identification, fertility, pregnancy, chronic follow-up and uncertainty. The 2024 NMC curriculum and the learner's institutional logbook should be used to assign the exact local competency codes, because this guide does not invent a code where the national document or college mapping is ambiguous. Assessment should combine an applied vignette, interpretation of a hormone panel, an emergency station and a structured referral note rather than testing isolated facts alone.
Key Exam Pearls for NEET PG
A low free T4 with an inappropriately low, normal or only mildly raised TSH points toward central hypothyroidism; TSH alone neither screens nor titrates it reliably. In suspected multiple pituitary deficits, protect the adrenal axis before giving levothyroxine. An intermediate morning cortisol is not a licence to guess: interpret the local assay and use an appropriate supervised dynamic test. ACTH deficiency usually preserves aldosterone because the renin-angiotensin system controls it, so hyperkalaemia is less typical than in primary adrenal failure. A pituitary mass with very high prolactin may be a prolactinoma, but modest elevation can result from stalk interruption; assay dilution may be needed when a large tumour and unexpectedly low prolactin raise the hook-effect possibility. Adult growth-hormone deficiency generally cannot be diagnosed from symptoms or a single random GH, and IGF-1 is influenced by nutrition, liver function and diabetes. Sudden headache, ophthalmoplegia and visual loss suggest apoplexy. Postpartum haemorrhage followed by lactation failure and amenorrhoea suggests Sheehan syndrome. New diabetes insipidus with a sellar lesion raises concern for stalk, hypothalamic, inflammatory or metastatic disease. Long-term cranial irradiation can cause sequential deficits years later. Replacement treats consequences; MRI surveillance and causal therapy address the lesion. Exam answers should separate an emergency action, a confirmatory test and definitive multidisciplinary care.
Frequently Asked Questions
Why must cortisol status be addressed before levothyroxine in hypopituitarism?
Thyroid hormone increases metabolic demand and cortisol clearance. In a person with unrecognized ACTH deficiency, starting levothyroxine can expose inadequate cortisol reserve and precipitate haemodynamic deterioration or adrenal crisis. Clinicians therefore establish cortisol sufficiency or provide glucocorticoid cover first, then treat central hypothyroidism and monitor free T4 rather than relying on TSH. This sequencing applies even when thyroid symptoms appear more prominent, because preventing an immediately dangerous cortisol deficit takes priority over gradual thyroid correction.
Can one normal pituitary hormone result exclude hypopituitarism?
No. Deficiencies may be selective, develop sequentially after surgery or radiotherapy, and appear deceptively normal when a trophic hormone is inappropriate for the low target hormone. Timing, acute illness, medicines, assay platform and binding proteins also alter interpretation. Diagnosis integrates paired basal results, validated dynamic tests when required, structural context and repeated assessment over time. A result must be judged against the expected physiological response, not merely whether the laboratory has printed it inside a population reference interval.
How is pregnancy planned in a woman with hypopituitarism?
Preconception review should confirm adrenal and thyroid replacement, assess tumour size and visual risk, discuss fertility treatment and establish who will adjust doses and manage labour or intercurrent illness. Pregnancy changes binding proteins and hormone requirements, while some dynamic tests and imaging choices differ. Care is coordinated between endocrinology, obstetrics and, when relevant, pituitary surgery specialists. The plan should state stress-dose arrangements for delivery and whom to contact if headache, visual symptoms, vomiting or haemodynamic instability occurs.
Does every adult with hypopituitarism need growth hormone replacement?
No. Symptoms are nonspecific and most adults require biochemical confirmation with a validated stimulation test after other hormone deficits are corrected. Treatment is individualized according to confirmed deficiency, age, quality-of-life burden, metabolic and skeletal context, contraindications, adverse effects, monitoring capacity and affordability. Evidence of benefit varies by outcome, so a supervised therapeutic decision is preferable to routine prescribing. A low IGF-1 alone is insufficient in many adults, particularly when malnutrition, liver disease or poorly controlled diabetes could explain the value. Follow-up must also establish whether any meaningful patient-centred benefit outweighs treatment burden.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic